CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

This is an archived document. The links are no longer being updated.

2001 Surveillance Slides

Completion of TB Therapy
United States, 1993-1999

Tuberculosis in the United States
Slide 25: Completion of TB Therapy, United States, 1993-1999. The reporting areas began collecting information on completion of therapy in 1993 through the individual TB case report form. This slide is based on data received at CDC by April 2002. Patients with an initial isolate resistant to rifampin and children with meningeal, bone or joint, or miliary disease were excluded from the calculations. Overall completion remained at approximately 90%; however, completion of therapy in 1 year or less increased from <65% in 1993 to 80% in 1998 and 1999. The current national program goal is completion of therapy in 1 year or less in 90% of patients. CDC is working with state and local health departments to evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333